The FDA's efforts to speed approvals of drugs to fight antibiotic-resistant bacteria will be front and center Monday as the agency considers two new antibiotics with possible advantages.
from WSJ.com: US Business http://ift.tt/1ogyqNH
via IFTTT
from WSJ.com: US Business http://ift.tt/1ogyqNH
via IFTTT
No comments:
Post a Comment